Alignment Healthcare CMO sells 35,951 shares
Alignment Healthcare, Inc. Chief Medical Officer Hyong Kim reported an open-market sale of common stock.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Alignment Healthcare, Inc. Chief Medical Officer Hyong Kim reported an open-market sale of common stock. On June 12, 2026, Kim sold 35,951 shares at a weighted-average price of $19.8589 per share under a pre-arranged Rule 10b5-1 plan adopted on March 13, 2026.
After this transaction, Kim directly holds 331,750 shares of Alignment Healthcare common stock. The filing shows a single net-sell transaction with no derivative exercises or gifts disclosed in this report.
Insider Trade Summary 10b5-1
Net Seller: 35,951 shares
Net Sell
1 txn
Insider
Kim Hyong
Role
Chief Medical Officer
Sold
35,951 shs ($714K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 35,951 | $19.8589 | $714K |
Holdings After Transaction:
Common Stock — 331,750 shares (Direct)
Footnotes (2)
- F1. Date of Rule 10b5-1 plan adoption: 03/13/2026
- F2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.57 to $20.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
Key Figures
Shares sold: 35,951 shares
Weighted-average sale price: $19.8589 per share
Post-transaction holdings: 331,750 shares
+3 more
6 metrics
Shares sold
35,951 shares
Open-market sale on June 12, 2026
Weighted-average sale price
$19.8589 per share
Common stock sale on June 12, 2026
Post-transaction holdings
331,750 shares
Direct ownership after reported sale
Sale price range
$19.57 to $20.24 per share
Multiple trades comprising the reported sale
Rule 10b5-1 plan adoption date
March 13, 2026
Pre-arranged trading plan governing the sale
Net shares sold in filing
35,951 shares
TransactionSummary net-sell direction
Key Terms
Rule 10b5-1 plan, weighted-average price, open-market sale, Form 4
4 terms
Rule 10b5-1 plan regulatory
"Date of Rule 10b5-1 plan adoption: 03/13/2026"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
weighted-average price financial
"The reported price in column 4 is a weighted-average price."
Weighted-average price is the average of multiple prices where each price is counted according to its size or importance—larger trades carry more weight than smaller ones, like averaging course grades by credit hours. It matters to investors because it gives a more realistic picture of the true price paid or received, helping assess trade execution, compare performance, calculate cost basis, and value positions more accurately than a simple average.
open-market sale financial
"transaction_action: open-market sale"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Alignment Healthcare (ALHC) disclose for Hyong Kim?
Alignment Healthcare’s Chief Medical Officer, Hyong Kim, reported selling 35,951 common shares. The sale occurred on June 12, 2026, as an open-market transaction and was executed under a pre-arranged Rule 10b5-1 trading plan adopted earlier in March 2026.
Was Hyong Kim’s ALHC stock sale made under a Rule 10b5-1 plan?
Yes. The filing states the transaction was made under a Rule 10b5-1 trading plan adopted on March 13, 2026. Such plans allow pre-scheduled trades, which can make the timing of insider sales more routine and less discretionary.
AI-generated analysis. How Rhea-AI works. Not financial advice.
